Speaker illustration

Doctor Emmanuel Sorbets

Hospital Hotel-Dieu, Paris (France)

CLARIFY.

Event: ESC CONGRESS 2019

Topic: Epidemiology, Prognosis, Outcome

Session: Meet the trialist - CLARIFY

Thumbnail

CLARIFY - In stable coronary disease, patients with angina and prior myocardial infarction have a poor prognosis despite adherence to guideline recommended therapies. Final 5-year results from the CLARIFY study

Event: ESC CONGRESS 2019

Topic: Epidemiology, Prognosis, Outcome

Session: Hot Line Session 5

Thumbnail

Frequency, management and outcomes of patients with stable coronary artery disease eligible for COMPASS. An analysis of the CLARIFY registry.

Event: ESC CONGRESS 2019

Topic: Epidemiology, Prognosis, Outcome

Session: Antithrombotic therapy for coronary artery disease: opportunities and challenges

Thumbnail

Prevalence, incidence and prognostic implications of left bundle branch block in patients with stable coronary artery disease. an analysis from the CLARIFY registry

Event: ESC CONGRESS 2019

Topic: Epidemiology, Prognosis, Outcome

Session: Coronary artery disease and comorbidities

Thumbnail

Outcomes of stable coronary artery disease worldwide. Insights from the CLARIFY registry

Event: ESC Congress 2018

Topic: Epidemiology, Prognosis, Outcome

Session: Coronary artery disease - Miscellaneous 1

Thumbnail

CLARIFY - First-line anti-ischemic agents use and long-term clinical outcomes in stable coronary artery disease

Event: ESC Congress 2018

Topic: Epidemiology, Prognosis, Outcome

Session: Late Breaking Pharmacological Science

Thumbnail

This platform is supported by

logo Novo Nordisk